Gynaecological and Obstetric Management of Women With Inherited Bleeding Disorders

Journal of Obstetrics and Gynaecology Canada

Volumn 27, Issue 7, 2005, Pages 707-718

  Demers, Christine ^a   Derzko, Christine ^a   David, Michele ^a   Douglas, Joanne ^a   Francoeur, Diane ^a   Garvey, Bernadette ^a   Israels, Sara ^a   Lillicrap, David ^a   Rivard, Georges Etienne ^a   Scully, Mary Frances ^a   Vickars, Linda ^a  

^a NONE   (Canada)

Author keywords

Coagulation disorder; Menorrhagia; Pregnancy; Von Willebrand

Indexed keywords

BLOOD CLOTTING FACTOR 8 PLUS VON WILLEBRAND FACTOR; DANAZOL; DESMOPRESSIN; GONADORELIN DERIVATIVE; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; TRANEXAMIC ACID;

ARTICLE; BLEEDING DISORDER; BLOOD EXAMINATION; DIFFERENTIAL DIAGNOSIS; ENDOMETRIUM ABLATION; FEMALE; GENETIC DISORDER; GYNECOLOGICAL EXAMINATION; HUMAN; HYSTERECTOMY; IRON DEFICIENCY; LABOR; MEDICAL ASSESSMENT; MENARCHE; MENORRHAGIA; NEWBORN CARE; OBSTETRIC ANESTHESIA; OBSTETRIC DELIVERY; PICTORIAL BLOOD ASSESSMENT; PREGNANCY; PUERPERIUM; VON WILLEBRAND DISEASE; BLOOD CLOTTING DISORDER; CANADA; EVIDENCE BASED MEDICINE; GENETICS; GYNECOLOGY; MEDICAL SOCIETY; OBSTETRICS; PRACTICE GUIDELINE; PREGNANCY COMPLICATION; STANDARD;

BLOOD COAGULATION DISORDERS; CANADA; EVIDENCE-BASED MEDICINE; FEMALE; GYNECOLOGY; HUMANS; OBSTETRICS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; SOCIETIES, MEDICAL;

EID: 26944447900     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)30551-5     Document Type: Article

References (54)

1. Speroff L Dysfunctional uterine bleeding. Clinical Gynecologic Endocrinology and Infertility 1999, Lippincott, Williams & Wilkins, Baltimore. 6th ed. L. Speroff, R. Glass, C. Kase (Eds.).
2. Ragni MV, Bontempo FA, Hassett AC von Willebrand disease and bleeding in women. Haemophilia 1999, 5:313-317.
3. Kouides PA, Phatak PD, Burkart P, Braggins C, Cox C, Bernstein Z, et al. Gynaecological and obstetrical morbidity in women with type 1 von Willebrand disease: results of a patient survey. Haemophilia 2000, 6:643-648.
4. Kadir RA, Economides DL, Sabin CA, Pollard D, Lee CA Assessment of menstrual blood loss and gynecological problems in patients with inherited bleeding disorders. Haemophilia 1999, 5:40-48.
5. Kadir RA, Economides DL, Lee CA Factor XT deficiency in women. Am J Hematol 1999, 60:48-54.
6. Kadir RA, Economides DL, Sabin CA, Ovens D, Lee CA Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998, 351:485-489.
7. van Eijkeren MA, Christiaens GC, Sixma JJ, Haspels AA Menorrhagia: a review. Obstet Gynecol Surv 1989, 44:421-429.
8. Edlund M, Blornback M, von Schoultz B, Andersson O On the value of menorrhagia as a predictor for coagulation disorders. Am J Hematol 1996, 53:234-238.
9. Dilley A, Drews C, Miller C, Lally C, Austin H, Ramaswamy D, et al. von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia. Obstet Gynecol 2001, 97:630-636.
10. Barr RD, Sek J, Horsman J, Furlong W, Saleh M, Pai M, et al. Health status and health-related quality of life associated with von Willebrand Disease. Am J Hematol 2003, 73:108-114.
11. Kouides PA, Burkart P, Phatak PD, Porter J, Peacock L, Braggins C, et al. The substantial impact of von Willebrand disease on menstruation. Update Ob Gyns 1998, 5:153-154.
12. Kadir RA, Sabin CA, Pollard D, Lee CA, Economides DL Quality of life during menstruation in patients with inherited bleeding disorders. Haemophilia 1998, 4:836-841.
13. Woolf SH, Battista RN, Angerson GM, Logan AG, Eel W Canadian Task Force on the Periodic Health Exam 1994, xxxvii. Canada Communication Group, Ottawa.
14. Rees MCP, Chimbira TH, Anderson ABM, Turnbull AC Menstrual blood loss: measurement and clinical correlates. Research and Clinical Forums 1982, 4:69-80.
15. Kouides PA Obstetric and gynaecological aspects of von Willebrand disease. Best Pract Res Clin Haematol 2001, 14:381-399.
16. Higham JM, O'Brien PM, Shaw RW Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990, 97:734-739.
17. SOGC Clinical Practice Guidelines: Guidelines for the management of abnormal uterine bleeding. J Obstet Gynaecol Can 2001, 106:1-6.
18. Sadler JE, Mannucci PM, Berntorp E, Bochkov N, Boulyjenkov V, Ginsburg D, et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost 2000, 84:160-174.
19. Irvine GA, Cameron IT Medical management of dysfunctional uterine bleeding. Bailheres Best Pract Res Clin Obstet Gynaecol 1999, 13:189-202.
20. von Willebrand's disease in gynecologic practice. Int J Gynecol Obstet 2002, 76:336-337. ACOG Committee Opinion. ACOG Bulletin No. 263.
21. Foster PA The reproductive Health of women with von Willebrand Disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thromb Haemost 1995, 74:784-790.
22. Stewart A, Cummins C, Gold L, Jordan R, Phillips W The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic review. Br J Obstet Gynaecol 2001, 108:74-86.
23. Lethaby AE, Cooke I, Rees M. Progesterone/progestogen releasing intrauterine systems versus either placebo or any other medication for heavy menstrual bleeding (Cochrane Review). In: The Cochrane Library, Issue 1, 2001. Oxford: Update Software.
24. Siegel JE, Kouides PA Menorrhagia from a haematologist's point of view. Part II: management Haemophilia 2002, 8:339-347.
25. Lethaby A, Farquhar C, Cooke I Antifibrinolytics for heavy menstrual bleeding (Cochrane Review). The Cochrane Library 2001, Update Software, Oxford, Issue 1.
26. Onundarson PT Treatment of menorrhagia in von Willebrand's disease. Haemophilia 1999, 5:76.
27. Ong YL, Hull DR, Mayne EE Menorrhagia in von Willebrand disease successfully treated with single daily dose tranexamic acid. Haemophilia 1998, 4:63-65.
28. Mannucci PM Desmopressin: a nontransfusional hemostatic agent. Annu Rev Med 1990, 41:55-64.
29. DiMichele DM Hathaway WE Use of DDAVP in inherited and acquired platelet dysfunction. Am J Hematol 1990, 33:39-45.
30. Lethagen S, Harris AS, Sjorin E, Nilsson IM Intranasal and intravenous administration of desmopressin: effect on F VIII/vWF, pharmacokinetics and reproducibility. Thromb Haemost 1987, 58:1033-1036.
31. Lethagen S, Ragnarson Tennvall G Self-treatment with desmopressin intranasal spray in patients with bleeding disorders: effect on bleeding symptoms and socioeconomic factors. Ann Hematol 1993, 66:257-260.
32. Rodeghiero F, Castaman G, Mannucci PM Prospective multicenter study on subcutaneous concentrated desmopressin for home treatment of patients with von Willebrand disease and mild or moderate hemophilia A. Thromb Haemost 1996, 76:692-696.
33. Kadir RA, Lee CA, Sabin CA, Pollard D, Economides DL DDAVP nasal spray for treatment of menorrhagia in women with inherited bleeding disorders: a randomized placebo-controlled crossover study. Haemophilia 2002, 8:787-793.
34. Mannucci PM, Bettega D, Cattaneo M Patterns of development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP). Br J Haematol 1992, 82:87-93.
35. Smith TJ, Gill JC, Ambruso DR, Hathaway WE Hyponatremia and seizures in young children given DDAVP. Am J Hematol 1989, 31:199-202.
36. Avouac B, Combe B, Dame B Prescription of NSAIDs in patients treatment with platelet inhibitors or anticoagulants. Presse Med 2003, 32:S38-S43.
37. Castaman G, Ruggeri M, Rodeghiero F Clinical usefulness of desmopressin for prevention of surgical bleeding in patients with symptomatic heterozygous Factor XI deficiency. Br J Haematol 1996, 94:168-170.
38. Aletebi FA, Vilos GA, Eskandar MA Thermal balloon endometrial ablation to treat menorrhagia in high-risk surgical candidates. J Am Assoc Gynecol Laparosc 1999, 6:435-439.
39. Claessens E, Cowell CA Acute adolescent menorrhagia. Am J Obstet Gynecol 1981, 139:277-280.
40. Chediak JR, Alban GM, Maxey B von Willebrand's disease and pregnancy: management during delivery and outcome of offspring. Am J Obstet Gynecol 1986, 155:618-624.
41. Ramsahoye BH, Davies SV, Dasani H, Pearson JF Obstetric management in von Willebrand's disease: a report of 24 pregnancies and a review of the literature. Hemophilia 1995, 1:140-144.
42. Kadir RA, Lee CA, Sabin CA, Pollard D, Economides DL Pregnancy in women with von Willebrand's disease or factor XI deficiency. Br J Obstet Gynaecol 1998, 105:314-321.
43. Greer IA, Lowe GDO, Walker JJ, Forbes CD Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. Br J Obstet Gynecol 1991, 98:909-918.
44. Noller KL, Bowie EJW, Kempers RD, Owen F, Owen CA Von Willebrand's disease in pregnancy. Obstet Gynecol 1973, 41:865-872.
45. Kadir RA Women and inherited bleeding disorders: pregnancy and delivery. Semin Hematol 1999, 36(Supp4):28-35.
46. Ljung R, Lindgren A-C, Petrini P, Tengborn L Normal vaginal delivery is to be recommended for haemophilia carrier gravidae. Acta Paediatr 1994, 83:609-611.
47. Kadir RA, Economides DL, Braithwaite J, Goldman E, Lee CA The obstetric experience of carriers of haemophilia. Br J Obstet Gynaecol 1997, 104:803-810.
48. Milaskiewicz RM, Holdcroft A, Letsky E Epidural anaesthesia and von Willebrand's disease. Anaesthesia 1990, 45:462-464.
49. Cohen S, Daitch JS, Amar D, Goldiner PL Epidural analgesia for labor and delivery in a patient with von Willebrand's disease. Regional Anesth 1989, 14:95-97.
50. Horlocker TT, Wedel DJ, Benzon H, Brown DL, Enneking FK, Heir JA, et al. Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med 2003, 28:172-197.
51. Sutor AH, von Kries R, Comellssen EAM, McNinch AW, Andrew M Vitamin K deficiency bleeding (VKDB) in infancy. Thromb Haemost 1999, 81:456-461.
52. Mannucci PM Treatment of von Willebrand disease. Thromb Haemost 2001, 80:149-153.
53. Ray JG, Boskovic R, Knie B, Hard M, Portnoi G, Koren G In vitro analysis of human transplacental transport of desmopressin. Clin Biochem 2004, 37:10-13.
54. Ray JG DDAVP use during pregnancy: an analysis of its safety for mother and child. Obstet Gynecol Surv 1998, 53:450-455.